Dr. Jou, Yuh-Shan
周玉山 博士
INTRODUCTION
實驗室介紹
NEWS
最新消息
HIGHLIGHTS
重要成果
PUBLICATIONS
研究論文
MEMBERS
實驗室成員
JOB
徵人啟事
ALBUM
相簿
HIGHLIGHTS
重要成果
Somatic A-to-I RNA-edited RHOA isoform 2 specific-R176G mutation promotes tumor progression in lung adenocarcinoma
Molecular Carcinogenesis, Dec 01, 2022
Adenosine-to-inosine (A-to-I) RNA editing is the most common posttranscriptional editing to create somatic mut ......
MORE 更多
Prognostic comparative genes predict targets for sorafenib combination therapies in hepatocellular carcinoma
Comput Struct Biotechnol J, Apr 20, 2022
With the increasing incidence and mortality of human hepatocellular carcinoma (HCC) worldwide, revealing innov ......
MORE 更多
PSPC1 is a new contextual determinant of aberrant subcellular translocation of oncogenes in tumor progression
Journal of Biomedical Science, Aug 02, 2021
Dysregulation of nucleocytoplasmic shuttling is commonly observed in cancers and emerging as a cancer hallmark for the d ......
MORE 更多
PSPC1 Potentiates IGF1R Expression to Augment Cell Adhesion and Motility
Cells, Jun 18, 2020
Abstract Paraspeckle protein 1 (PSPC1) overexpression in cancers is known to be the pro-metastatic switch of tumor progression associat ......
MORE 更多
Integrative analyses of noncoding RNAs reveal the potential mechanisms augmenting tumor malignancy in lung adenocarcinoma
Nucleic Acids Research, Dec 19, 2019
Precise noncoding RNA (ncRNA)-based network prediction is necessary to reveal ncRNA functions and pathological mechanisms. Here, we establis ......
MORE 更多
« previous 1
2
3
4
next »
List of Highlights
文件紀錄
Somatic A-to-I RNA-edited RHOA isoform 2 specific-R176G mutation promotes tumor progression in lung adenocarcinoma
Molecular Carcinogenesis Dec 01, 2022
Prognostic comparative genes predict targets for sorafenib combination therapies in hepatocellular carcinoma
Comput Struct Biotechnol J Apr 20, 2022
PSPC1 is a new contextual determinant of aberrant subcellular translocation of oncogenes in tumor progression
Journal of Biomedical Science Aug 02, 2021
PSPC1 Potentiates IGF1R Expression to Augment Cell Adhesion and Motility
Cells Jun 18, 2020
Integrative analyses of noncoding RNAs reveal the potential mechanisms augmenting tumor malignancy in lung adenocarcinoma
Nucleic Acids Research Dec 19, 2019
PSPC1-interchanged interactions with PTK6 and β-catenin synergize oncogenic subcellular translocations and tumor progression
Nature Communications Dec 16, 2019
A New Switch for TGFβ in Cancer
Cancer Research Jul 12, 2019
PSPC1 mediates TGF-β1 autocrine signalling and Smad2/3 target switching to promote EMT, stemness and metastasis
Nature cell biology Mar 28, 2018
EIF3C-enhanced exosome secretion promotes angiogenesis and tumorigenesis of human hepatocellular carcinoma
Oncotarget Jan 11, 2018
Pyrimidine metabolic rate limiting enzymes in poorly-differentiated hepatocellular carcinoma are signature genes of cancer stemness and associated with poor prognosis
Oncotarget Sep 08, 2017
Overexpressed-eIF3I interacted and activated oncogenic Akt1 is a theranostic target in human hepatocellular carcinoma.
Hepatology. Mar 04, 2013
HDAC inhibitors augmented cell migration and metastasis through induction of PKCs leading to identification of low toxicity modalities for combination cancer therapy.
Clin Cancer Res. Jul 18, 2012
IGDB.NSCLC: integrated genomic database of non-small cell lung cancer.
Nucl. Acids Res Dec 01, 2011
Somatic LMCD1 mutations promoted cell migration and tumor metastasis in hepatocellular carcinoma.
Oncogene Sep 26, 2011
IGRhCellID: integrated genomic resources of human cell lines for identification.
Nucleic Acids Research Nov 04, 2010
Overlapping high-resolution copy number alterations in cancer genomes identified putative cancer genes in hepatocellular carcinoma.
Hepatology Aug 31, 2010
OncoDB.HCC: an integrated oncogenomic database of hepatocellular carcinoma revealed aberrant cancer target genes and loci .
Nucleic Acids Research. Nov 10, 2006
Top